389 related articles for article (PubMed ID: 28454844)
1. Serum miRNAs miR-206, 143-3p and 374b-5p as potential biomarkers for amyotrophic lateral sclerosis (ALS).
Waller R; Goodall EF; Milo M; Cooper-Knock J; Da Costa M; Hobson E; Kazoka M; Wollff H; Heath PR; Shaw PJ; Kirby J
Neurobiol Aging; 2017 Jul; 55():123-131. PubMed ID: 28454844
[TBL] [Abstract][Full Text] [Related]
2. Correlating serum micrornas and clinical parameters in amyotrophic lateral sclerosis.
Raheja R; Regev K; Healy BC; Mazzola MA; Beynon V; Von Glehn F; Paul A; Diaz-Cruz C; Gholipour T; Glanz BI; Kivisakk P; Chitnis T; Weiner HL; Berry JD; Gandhi R
Muscle Nerve; 2018 Aug; 58(2):261-269. PubMed ID: 29466830
[TBL] [Abstract][Full Text] [Related]
3. Identification of a circulating miRNA signature in extracellular vesicles collected from amyotrophic lateral sclerosis patients.
Saucier D; Wajnberg G; Roy J; Beauregard AP; Chacko S; Crapoulet N; Fournier S; Ghosh A; Lewis SM; Marrero A; O'Connell C; Ouellette RJ; Morin PJ
Brain Res; 2019 Apr; 1708():100-108. PubMed ID: 30552897
[TBL] [Abstract][Full Text] [Related]
4. Assessment of diagnostic potential of some circulating microRNAs in Amyotrophic Lateral Sclerosis Patients, an Egyptian study.
Soliman R; Mousa NO; Rashed HR; Moustafa RR; Hamdi N; Osman A; Fahmy N
Clin Neurol Neurosurg; 2021 Sep; 208():106883. PubMed ID: 34454204
[TBL] [Abstract][Full Text] [Related]
5. Identification of plasma microRNAs as a biomarker of sporadic Amyotrophic Lateral Sclerosis.
Takahashi I; Hama Y; Matsushima M; Hirotani M; Kano T; Hohzen H; Yabe I; Utsumi J; Sasaki H
Mol Brain; 2015 Oct; 8(1):67. PubMed ID: 26497046
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide circulating microRNA expression profiling reveals potential biomarkers for amyotrophic lateral sclerosis.
Matamala JM; Arias-Carrasco R; Sanchez C; Uhrig M; Bargsted L; Matus S; Maracaja-Coutinho V; Abarzua S; van Zundert B; Verdugo R; Manque P; Hetz C
Neurobiol Aging; 2018 Apr; 64():123-138. PubMed ID: 29458840
[TBL] [Abstract][Full Text] [Related]
7. Identification of miRNAs as Potential Biomarkers in Cerebrospinal Fluid from Amyotrophic Lateral Sclerosis Patients.
Benigni M; Ricci C; Jones AR; Giannini F; Al-Chalabi A; Battistini S
Neuromolecular Med; 2016 Dec; 18(4):551-560. PubMed ID: 27119371
[TBL] [Abstract][Full Text] [Related]
8. Differential Expression of miRNAs in Amyotrophic Lateral Sclerosis Patients.
Gomes BC; Peixinho N; Pisco R; Gromicho M; Pronto-Laborinho AC; Rueff J; de Carvalho M; Rodrigues AS
Mol Neurobiol; 2023 Dec; 60(12):7104-7117. PubMed ID: 37531027
[TBL] [Abstract][Full Text] [Related]
9. Serum microRNAs in sporadic amyotrophic lateral sclerosis.
Freischmidt A; Müller K; Zondler L; Weydt P; Mayer B; von Arnim CA; Hübers A; Dorst J; Otto M; Holzmann K; Ludolph AC; Danzer KM; Weishaupt JH
Neurobiol Aging; 2015 Sep; 36(9):2660.e15-20. PubMed ID: 26142125
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs-424 and 206 are potential prognostic markers in spinal onset amyotrophic lateral sclerosis.
de Andrade HM; de Albuquerque M; Avansini SH; de S Rocha C; Dogini DB; Nucci A; Carvalho B; Lopes-Cendes I; França MC
J Neurol Sci; 2016 Sep; 368():19-24. PubMed ID: 27538595
[TBL] [Abstract][Full Text] [Related]
11. Circulating RNAs as Potential Biomarkers in Amyotrophic Lateral Sclerosis.
Ravnik-Glavač M; Glavač D
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32138249
[TBL] [Abstract][Full Text] [Related]
12. Circulating miR-181 is a prognostic biomarker for amyotrophic lateral sclerosis.
Magen I; Yacovzada NS; Yanowski E; Coenen-Stass A; Grosskreutz J; Lu CH; Greensmith L; Malaspina A; Fratta P; Hornstein E
Nat Neurosci; 2021 Nov; 24(11):1534-1541. PubMed ID: 34711961
[TBL] [Abstract][Full Text] [Related]
13. Association between oxidative stress and microRNA expression pattern of ALS patients in the high-incidence area of the Kii Peninsula.
Arakawa Y; Itoh S; Fukazawa Y; Ishiguchi H; Kohmoto J; Hironishi M; Ito H; Kihira T
Brain Res; 2020 Nov; 1746():147035. PubMed ID: 32739158
[TBL] [Abstract][Full Text] [Related]
14. Circulating microRNAs as biomarkers for disease staging in multiple sclerosis.
Gandhi R; Healy B; Gholipour T; Egorova S; Musallam A; Hussain MS; Nejad P; Patel B; Hei H; Khoury S; Quintana F; Kivisakk P; Chitnis T; Weiner HL
Ann Neurol; 2013 Jun; 73(6):729-40. PubMed ID: 23494648
[TBL] [Abstract][Full Text] [Related]
15. Circulating microRNAs as biomarkers in progressive multiple sclerosis.
Vistbakka J; Elovaara I; Lehtimäki T; Hagman S
Mult Scler; 2017 Mar; 23(3):403-412. PubMed ID: 27246141
[TBL] [Abstract][Full Text] [Related]
16. Signature of miRNAs derived from the circulating exosomes of patients with amyotrophic lateral sclerosis.
Cheng YF; Gu XJ; Yang TM; Wei QQ; Cao B; Zhang Y; Shang HF; Chen YP
Front Aging Neurosci; 2023; 15():1106497. PubMed ID: 36845651
[TBL] [Abstract][Full Text] [Related]
17. Identification of let-7f and miR-338 as plasma-based biomarkers for sporadic amyotrophic lateral sclerosis using meta-analysis and empirical validation.
Daneshafrooz N; Joghataei MT; Mehdizadeh M; Alavi A; Barati M; Panahi B; Teimourian S; Zamani B
Sci Rep; 2022 Jan; 12(1):1373. PubMed ID: 35082326
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the causal association between microRNAs and amyotrophic lateral sclerosis.
Zhu Y; Li M; He Z; Pang X; Du R; Yu W; Zhang J; Bai J; Wang J; Huang X
Neurol Sci; 2023 Oct; 44(10):3567-3575. PubMed ID: 37261630
[TBL] [Abstract][Full Text] [Related]
19. Plasma microRNA signature in presymptomatic and symptomatic subjects with
Kmetzsch V; Anquetil V; Saracino D; Rinaldi D; Camuzat A; Gareau T; Jornea L; Forlani S; Couratier P; Wallon D; Pasquier F; Robil N; de la Grange P; Moszer I; Le Ber I; Colliot O; Becker E;
J Neurol Neurosurg Psychiatry; 2021 May; 92(5):485-493. PubMed ID: 33239440
[TBL] [Abstract][Full Text] [Related]
20. Differential Expression of MicroRNAs and Predicted Drug Target in Amyotrophic Lateral Sclerosis.
Patel RB; Bajpai AK; Thirumurugan K
J Mol Neurosci; 2023 Jun; 73(6):375-390. PubMed ID: 37249795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
